RT Journal Article
SR Electronic
T1 Nurses’ Satisfaction with and Demand for the National Cancer Patient Home-Care Pilot Program
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.21.23298855
DO 10.1101/2023.11.21.23298855
A1 Kim, Jung Ha
A1 Lee, Jang Won
A1 Kim, Jung Yoon
A1 Hong, Yong Eun
A1 Jang, Sol Bi
A1 Lee, Woo Jeong
A1 Oh, Kyung Hee
A1 Kim, Young Ae
YR 2023
UL http://medrxiv.org/content/early/2023/11/22/2023.11.21.23298855.abstract
AB In December 2021, the “National Cancer Patient Home-Care Pilot Program” was launched in South Korea. However, there were medical institutions with low participation and where services were not provided. Therefore, this study aimed to investigate the progress of, satisfaction with, and needs of nurses’ regarding a pilot program for home care of cancer patients with a stoma. Data were collected through a survey administered to nurses from November 13, 2022, to January 19, 2023; a total of 207 nurses responded. After excluding non-answers, 196 nurses were included in the final study population. The questionnaire sought information on the characteristics of the respondent, status of management of stoma patients, status of the home-care pilot program, satisfaction with the program, and needs of the nurses. The data were analyzed using descriptive statistics. A total of 196 nurses participated in the survey, of whom 42 nurses (21.4%) participated in the home-care pilot program. Thirty-five nurses (85.4 %) were satisfied with the home-care pilot program. Thirty nurses (71.4%) reported that implementation of home care had to be expanded and standards of care improved. To vitalize and expand the pilot program for home care for cancer patients with a stoma, better medical services must be provided by improving the medical fee standard. This will enable more patients and medical institutions to participate in the pilot program.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board of the NCC Center (IRB No.: NCC2022-0849).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableData are available from the National Cancer Center Ethics Committee for researchers who meet the criteria for access to confidential data.